## TruSight Oncology Comprehensive (EU)

The first CE-marked IVD kitted solution for comprehensive genomic profiling (CGP) of DNA and RNA variants, plus MSI and TMB, for multiple solid tumor types.

[View product](https://www.illumina.com/products/by-type/ivd-products/trusight-oncology-comprehensive.html)

## VeriSeq NIPT Solution v2

Comprehensive in-lab NIPT IVD solution including reagents, instruments, and software for accurate aneuploidy screening results in 26 hours.

[View product](https://www.illumina.com/products/by-type/ivd-products/veriseq-nipt.html)

## [Illumina DNA Prep with Enrichment Dx](https://www.illumina.com/products/by-type/ivd-products/dna-prep-enrichment-dx.html)

A library preparation and enrichment solution for IVD targeted sequencing applications.

## [MiSeqDx Reagent Kit v3](https://www.illumina.com/products/by-type/ivd-products/miseqdx-reagents.html)

A validated, FDA-regulated, CE-marked IVD sequencing reagent kit, offering improved quality scores compared to previous versions.

## [NextSeq 550Dx Reagents](https://www.illumina.com/products/by-type/ivd-products/nextseq-dx-reagents.html)

These sequencing reagent kits offer a simplified workflow and high data quality for _in vitro_ diagnostic testing on the NextSeq550 Dx Instrument.

## [NovaSeq 6000Dx Reagent Kits](https://www.illumina.com/products/by-type/ivd-products/novaseq-6000dx-reagents.html)

These sequencing reagent kits allow clinical laboratories to perform high-throughput _in vitro_ diagnostic testing on the NovaSeq 6000Dx instrument.

## [Pillar oncoReveal CDx](https://www.illumina.com/products/by-type/ivd-products/pillar-oncoreveal-cdx.html)

Pillar oncoReveal CDx is an FDA-approved, NGS-based companion diagnostic kit detecting variants in 22 clinically significant genes in solid tumor DNA.

Assay time: 48 hrs  
Hands-on time: 3.5 hr  
Input quantity: 30–80 ng DNA

## [TruSeq Custom Amplicon Kit Dx](https://www.illumina.com/products/by-type/ivd-products/truseq-custom-amplicon-dx.html)

A validated, FDA-regulated kit enabling clinical laboratories to design their own next-generation sequencing assays for use on the MiSeqDx and NextSeq 550Dx systems.

## [TruSight Cystic Fibrosis](https://www.illumina.com/products/by-type/ivd-products/trusight-cystic-fibrosis.html)

FDA-regulated, CE-marked _in vitro_ diagnostic (IVD) next-generation sequencing assay conveniently providing two cystic fibrosis tests in one product.

## [TruSight Oncology Comprehensive (EU)](https://www.illumina.com/products/by-type/ivd-products/trusight-oncology-comprehensive.html)

The first CE-marked IVD kitted solution for comprehensive genomic profiling (CGP) of DNA and RNA variants, plus MSI and TMB, for multiple solid tumor types.

## [TruSight Oncology Comprehensive](https://www.illumina.com/products/by-type/ivd-products/trusight-oncology-comprehensive-us.html)

The first US FDA-approved distributable comprehensive genomic profiling (CGP) IVD with pan-cancer companion diagnostic (CDx) claims.

Assay time: 4-5 days  
Hands-on time: ~10.5 hr  
Input quantity: 40 ng genomic DNA

## [TruSight Whole Genome](https://www.illumina.com/products/by-type/ivd-products/trusight-whole-genome.html)

An EU IVDR 2017/746-compliant, scalable whole-genome sequencing solution for clinical diagnostic testing.

## [VeriSeq NIPT Solution v2](https://www.illumina.com/products/by-type/ivd-products/veriseq-nipt.html)

Comprehensive in-lab NIPT IVD solution including reagents, instruments, and software for accurate aneuploidy screening results in 26 hours.

Designed, validated, and regulated for clinical use, Illumina _in vitro_ diagnostic (IVD) products include sequencing instruments, assays, library prep kits, and software.

Available in > 45 countries, the MiSeqDx is an in vitro diagnostic (IVD) next-generation sequencing instrument for diagnostics and clinical research.

Regulated platforms with stringent performance characteristics for diagnostic use.

Next-generation sequencing panels for detection of causative and clinically relevant variants for cystic fibrosis.